PPT-Anti-EGFL7 as a Novel Targeted Therapy in Acute Myeloid Leukemia

Sofia Kolovich 1 Allison LaRocco 1 Malith Karunasiri 1 Girish Rajgolikar 1 Allison Walker 1 Ramiro Garzon 1 Marius Bill 1 Adrienne Dorrance 1 1 The Ohio State University Comprehensive Cancer Center Division of Hematology The Ohio State University Columbus OH 43210. Marisa Juntilla, MD, PhD. Stanford University Medical Center Stanford, California. Case 121: 58 year old man . Past medical history:. type II diabetes, coronary artery disease and severe diverticulitis, 1 month status-post colectomy, reported normal CBCs at his yearly primary care visits. . Farhad. . Ravandi. , . MD. Professor of Medicine. University of Texas MD Anderson Cancer Center. Disclosure of Conflicts of Interest. Dr. . Ravandi. discloses that he is a consultant/advisor for Pfizer, . Cedar Mountain post acute rehabilitation center provide a therapeutic environment for our residents Yucaipa. Individualized treatment programs are developed with the interdisciplinary team of nursing, social services, Healthcare and dietary in consultation with your physicians. Hiba . El Hajj, Ph.D.. Assistant Professor, . Departments . of Internal Medicine. AND Experimental . Pathology, Immunology and Microbiology. Faculty of Medicine. American University of . Beirut. 1. L’OREAL-UNESCO. Dr. . B.V.Vydehi. M.D. PROFESSOR OF PATHOLOGY. NARAYANA MEDICAL COLLEGE,NELLORE. Uncontrolled & abnormal proliferation of one of white blood cells & their precursors in the bone marrow and peripheral blood. Arif Ali Awan – R2 JGH. November 27. th. , 2014. IM Teaching. Disclaimer. Just a Resident. Case. 52F Nurse, 3 sisters. PMHx. : HTN, hysterectomy. Meds: . Hctz. 12.5; NKDA. No family history. Presents with 6 week history of intermittent fever (. PROGNOSTIC FACTORS. Although the first published reports of leukemia occurred in 1845 by Bennett and Virchow, the lack of refined diagnostic methodology limited the distinction between myeloid and lymphoid acute leukemia, With the development of refined staining techniques, followed by microscopy and histochemical staining by the mid-20th century, this distinction was . precision . medicine at reach?. Lars . Bullinger. University of Ulm / MDC Berlin-. Buch. MODERN . PROBLEMS OF . GENETICS. dedicated . to the 115. th. anniversary of the birth of . N. W. . Timofeeff-Ressovsky. BSW00073 / OK 11 - ONC - 152 1 July , 2011 Fact Sheet Leukemia is a cancer that begins in the bone marrow ( the soft inner part of some bones), but in most cases, moves into the blood. It can t hen s Chimeric antigen T cell receptor treatment in Natasha Ali Aga Khan University Blood Research, 54 brought to you by CORE View metadata, citation and similar papers at core.ac.uk provided by eCommons@A Introduction to Leukemia. Definition. Historic Perspective. Etiology and Risk Factors . Incidence. Classification. Comparison of Acute and Chronic Leukemia. Leukemia. Definition. Leukemia is a malignant disease of hematopoietic tissue characterized by the accumulation abnormal white cells (neoplastic or leukemic) in the bone marrow leading to bone marrow failure, a raised circulating white cell count (leukocytosis) and infiltrate organs (e.g liver, spleen, lymph nodes, brain) . Kelsey Shaffer. CHTN. Staff Meeting Presentation. What is it?. Acute Lymphoblastic Leukemia (ALL) is a blood cancer. White Blood Cells (WBC). Lymphocytes or Lymphoblast . Too many immature WBC. Crowd the bone marrow. . A. ccumulation of abnormal blasts (. I. mmature precursors of WBC). . in bone marrow and blood leading to:. . 1- Bone marrow failure. . (. anemia ,neutropenia & thrombocytopenia). . 2- Organ infiltration . Jayllex Mills,. PharmD Candidate. AML Background. Hematologic malignancy affecting the blood and bone marrow. Result of proliferation of abnormal myeloid stem cell derivatives and interference of normal blood cell production.